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THE CASE 
 
A 53-year-old man is seen in clinic 4 months after receiving an orthotopic liver 
transplant (OLT) for two small (<3 cm in diameter) hepatomas which were discovered 
incidentally. The patient had a history of heavy alcohol use in his twenties and thirties, 
but has not used alcohol for over 10 years. Liver histology on the resected organ 
revealed early micronodular cirrhosis with the two tumor nodules localized to the right 
lobe. He has been well since leaving the hospital. His T-tube was removed 2 weeks 
prior to the clinic visit and subsequent endoscopic retrograde cholangiopancreatography 
(ERCP) (Figure 1). The patient experienced immediate severe discomfort when the tube 
was withdrawn and he was admitted to hospital for over-night observation and narcotic 
analgesia. The pain improved by the next day, when an abdominal ultrasound 
examination was performed; this showed no obvious fluid collection(s) that might 
suggest a bile leak. His pain persisted for about 1 week, and was managed with oral 
analgesia. Liver function tests (LFTs) carried out during the overnight hospitalization 
revealed mildly elevated serum bilirubin at 1.7 mg/dl (normal <1 mg/dl) with aspartate 
and alanine aminotransferases (AST and ALT) of 180 IU/l and 220IU/l, respectively 
(both mildly elevated). Alkaline phosphatase was also elevated, at 310 IU/l. 
Cytomegalo-virus (CMV) serology was positive (a conversion from negative before the 
transplant). 
 
As the abnormal LFT values have persisted, the patient has been sent with a request for 
ERCP to define his biliary anatomy. Figure 1 shows one view of his cholangiogram. 
The very distal part of the common bile duct (CBD) is obscured by the endoscope; there 
is also a pool of contrast in the duodenal bulb. Other views of the distal CBD show no 
evidence of obstruction. Bile appeared to drain freely from the papilla. 
 
 
 
MODERATOR'S QUESTIONS 
 
Based on the history provided, I would like to ask Dr Muñoz-Navas for his comments 
on the case. Was the ERCP indicated? How do you interpret the cholangiogram? Are 
any therapeutic interventions indicated? And what does the literature say about the 
utility of ERCP for evaluating abnormal liver serology following liver transplantation? 
 
 
 
GUEST DISCUSSANT'S REPLY 
 
Thank you very much for the invitation to review this interesting case. The patient is a 
53-year-old man who received an orthotopic liver transplant (OLT) in the setting of 
cirrhosis (probably alcoholic) with two small hepatocellular carcinomas (HCCs) of 
diameter <3 cm. This is a good indication for liver transplantation, because most 
hepatologists favor OLT for managing HCCs rather than liver resection, especially 
when the tumors are single and <5 cm in diameter, or when there are three or fewer 
nodules each <3 cm in diameter, without extrahepatic lesions. The reported 5-year 
survival of OLT in this setting is around 70% [1]. This patient made an uneventful 
recovery from his OLT and was able to leave the hospital for convalescence. 
 
At 4 months after getting his new liver, the patient experienced severe abdominal 
discomfort that was clearly related to the act of removing the T-tube. This episode 
required overnight hospital admission and narcotic analgesia. His laboratory tests 
showed elevations in serum bilirubin, ASL and ALT, and alkaline phosphatase. His 
CMV serology was noted to have converted from negative pre-operatively to positive. 
The abdominal pain slowly diminished but the patient needed oral analgesia for a week, 
and his LFT abnormalities persisted. For these reasons, ERCP was requested. The 
clinical data suggested a bile leak. We would have expected to visualize an abdominal 
fluid collection by ultrasound examination if the leak was of any magnitude. However, 
as the old saying goes, "absence of evidence is not evidence of absence": the leak may 
have been small and short-lived, with no significant accumulation of fluid. A repeat 
abdominal ultrasound examination would have been useful before proceeding with 
more invasive studies [2], to look for delayed accumulation of a "bilioma". Additional 
techniques for evaluating possible bile leaks include competed tomography scan, 
radionuclide (e. g. 
99m
Tc HIDA) scanning, and magnetic resonance cholangiography. 
The ERCP showed dilatation of the native (CBD) with a persistent T-tube track. There 
is a possible stricture at the duct-to-duct anastomosis with no dilatation above (i.e. of 
the donor bile duct). The dilatation of the native CBD is almost certainly the result of 
denervation secondary to surgery. Since the apparent "stricture" of the anastomosis does 
not cause dilatation above it, I do not consider it to be functionally important. Most 
small bile-duct leaks heal spontaneously [3]. However, it may be appropriate, in the 
setting of a suspected recent leak, to place a biliary stent or nasobiliary drain, or to 
perforen biliary sphincterotomy at the time of ERCP. In this particular case, I would 
have been tempted to place a 10-Fr straight biliary stent through the papilla without 
prior sphincterotomy. This is less troublesome for the patient than a nasobiliary drain 
and less likely to cause complications than a sphincterotomy. If biliary stones or sludge 
had been seen, we would have a good excuse for performing sphincterotomy. 
 
Inadvertent early removal of T-tubes is a well known cause of bile peritonitis. However, 
routine delay of T-tube removal (2-5 months) in transplant patients has not decreased 
the incidence of bile leakage [3]. This is because the maturation of the T-tube track in 
immunosuppressed liver-transplant patients takes much longer than in 
nonimmunosuppressed patients. For this reason, many centers have abandoned the 
routine use of T-tubes, with encouraging results [4,5]. 
 
ERCP is useful following OLT in patients with suspected biliary fistula or bile-duct 
obstruction. Endoscopic methods have been used to treat biliary leaks, strictures, 
stones/casts, and papillary stenosis related to transplantation [6]. Abnormal LFTs after 
OLT can be caused by a wide range of problems, not just bile leaks; other causes, such 
as hepatic arterial occlusion, allograft rejection, and viral infection have to be 
considered [3]. Liver biopsy may be helpful, especially when the diagnosis is rejection 
or viral (CMV) infection, the latter being encouraged by marked suppression of cell-
mediated immunity, which is also an independent risk factor for opportunistic and 
fungal infection [7]. Identified risk factors for post-OLT infection include the type of 
biliary anastomosis, transfusion requirement at surgery, surgical complications, duration 
of the surgery duration of post-operative ventilation, serologic status of the donor and 
recipient, steroid use, anti-lymphocyte serum use to treat rejection, and pre-transplant 
and post-transplant antibiotic use [8]. The three potential sources of CMV are the donor 
liver, cellular blood products, and reactivation of endogenous (latent) virus, which has a 
prevalence of around 75% in OLT recipients. Most of the clinical CMV syndromes 
occur in liver-transplant patients between the 3rd and 16th week after transplantation 
[9]. Clinically, it is very important to make the distinction between CMV disease and 
CMV infection. CMV disease is defined as an invasive CMV infection with either 
histologic evidence (pathognomonic CMV-infected cells with their characteristic 
inclusions or positive immunochemistry using in situ hybridization), or a positive CMV 
culture from deep tissue specimens (e. g. liver biopsy, endoscopic mucosal biopsy or 
brushings, etc), or demonstrated viremia in the setting of clinical manifestation [9]. In 
this patient, the change from seronegative to seropositive for CMV and the abnormal 
liver tests strongly suggest the possibility of graft dysfunction due to CMV disease. 
Patients with CMV disease are treated with a reduction, if possible, of the 
immunosuppressive treatment and (in particular) tapering of the steroid dose, plus 
specific antiviral therapy with ganciclovir. 
 
 
 
MODERATOR'S COMMENTS 
 
Dr Muñoz-Navas is correct in stating that the biliary anatomy is probably irrelevant to 
the patient's current problem with persistently abnormal liver serology (LFTs). The 
cholangiogram shows a persistent fistulous track at the site where the T-tube had been, 
and a narrowing at the site of the donor-to-recipient bile-duct anastomosis. It is not 
uncommon for there to be a mismatch between the donor and the recipient bile-duct 
diameter, causing the appearance of a possible stricture at the anastomosis. As our 
expert notes, the lack of dilatation above (proximal to) the "stricture" militates against 
significant mechanical obstruction. In fact, a small balloon was pulled through this site 
without resistance at the time of ERCP. The apparent fistula at the site where the T-tube 
had been has a blind ending, suggesting that it has sealed off. It is likely that the 
patient's acute pain attack was the result of a small bile leak at the time of the T-tube 
removal. The lack of a bile collection (biloma) on ultrasound scanning does not exclude 
this possibility. In this patient's case, the problem appears to have been self-limiting. As 
the patient's pain had all but resolved at the time of our ERCP, and we could not 
demonstrate a collection beyond the fistula, we felt that the abnormal LFTs were most 
likely due to parenchymal disease. However, the hepatologist managing the patient 
disagreed and requested that we place a stent to assess the effect. A 7-Fr straight stent 
was placed with the tip above the pseudostricture. The following day the liver tests were 
worse, with a bilirubin up to 3.3 mg/dl and equivalent rises in transaminases and 
alkaline phosphatase. The patient re-ported an increase in abdominal discomfort. 
Although the liver tests progressively returned to their pre-ERCP and stent-placement 
levels, we elected to remove the stent at day 5, considering it unlikely that further 
stenting would benefit this patient. A subsequent liver biopsy showed changes 
consistent with CMV infection of the graft. This was treated aggressively, as outlined 
above. This case serves to demonstrate that not every cholangiographic abnormality is 
indicative of active pathology. To paraphrase the famous saying, even if it walks like a 
duck, and quacks like a duck, in the post-transplant patient it may be a platypus! Many 
thanks to Dr Muñoz-Navas for his excellent evaluation of this case. 
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Figure 1. Cholangiogram obtained at endoscopic retrograde cholangiopancreatography 
(ERCP) in a 53-year-old man who previously had an orthotopic liver transplant (see text 
for details). 
 
 
 
 
